The 4 payer types to be considered in optimising value pricing in pharma

Payer research is essential for setting the right price for a new pharmaceutical. However, it's important to recognise that there is no single "payer." In this short video, Gary Johnson, expert faculty member teaching CELforPharma’s 2-day The Pharma Pricing Course, explains the different types of payers you need to consider before starting your pricing research.

Gary Johnson is a thought leader in this respect since he has been involved in pricing for around half of the new molecular entity launches over the past 5 years and is the author of Value Pricing for Market Access: Evidence-Based Pricing for Pharmaceuticals.

 

Value pricing is one of three types. Which one applies to your product:

→ Different types of pricing in pharma

 

Continue your learning from Gary and Sam

If you’d like to learn more from Gary and Sam, CELforPharma also offers a 2-day, hands-on course where you'll learn how to:

  • Analyse payer types and global pricing & market access systems
  • Recognise the role of health economics in pricing decisions, and its limits
  • Use evidence-based frameworks and AI to analyse & predict payer behaviour
  • Anticipate how international reference pricing affects your global strategy

Don’t miss the latest insights from our expert faculty

Subscribe to our newsletter to:

  • Stay on top of the latest expert insights
  • Receive invitations to upcoming educational webinars
  • Get updates on our courses and training programmes